目的探讨腹腔镜广泛性子宫全切术患者应用血栓风险评估对其术后下肢深静脉血栓(deep venous thrombosis,DVT)的预防效果。方法纳入2019年10月—2021年10月于新泰市人民医院行腹腔镜广泛性子宫全切术的98例患者,采用随机数字表法分为对...目的探讨腹腔镜广泛性子宫全切术患者应用血栓风险评估对其术后下肢深静脉血栓(deep venous thrombosis,DVT)的预防效果。方法纳入2019年10月—2021年10月于新泰市人民医院行腹腔镜广泛性子宫全切术的98例患者,采用随机数字表法分为对照组和观察组,各49例。对照组行常规护理,观察组在常规护理基础上增加血栓风险评估指引下的护理。比较2组DVT发生率、术后恢复情况、凝血功能[凝血酶时间(thrombin time,TT)、凝血酶原时间(prothrombin time,PT)和活化部分凝血活酶时间(activated partial thromboplastin time,APTT)]、生活质量和护理满意度。结果干预后,观察组DVT发生率低于对照组,首次肛门排气时间、肠鸣音恢复时间、首次进食时间、下床活动时间和住院时间短于对照组,TT、PT、APTT水平高于对照组,健康调查简表(the MOS item short from health survey,SF-36)评分、护理满意度高于对照组,差异有统计学意义(P<0.05)。结论腹腔镜广泛性子宫全切术患者应用血栓风险评估可降低DVT发生率,改善患者的凝血功能,促进患者术后恢复,提高患者的生活质量和护理满意度,值得临床借鉴。展开更多
新型冠状病毒肺炎(COVID-19)是一种呼吸道疾病,其主要通过呼吸道在人与人间传播,由SARS-CoV-2病毒引起。COVID-19经过传播导致疫病在全世界范围内大流行,快速扩张,对人类的健康及全球的经济发展造成了不可估量的危害。目前研究证据表明,...新型冠状病毒肺炎(COVID-19)是一种呼吸道疾病,其主要通过呼吸道在人与人间传播,由SARS-CoV-2病毒引起。COVID-19经过传播导致疫病在全世界范围内大流行,快速扩张,对人类的健康及全球的经济发展造成了不可估量的危害。目前研究证据表明,COVID-19已发生多次变异,传染性极高,病毒载量增加,COVID-19大流行大大增加了许多患者发生静脉和动脉血栓栓塞事件的风险,因此,全面认识COVID-19血栓风险及治疗进展对新型冠状病毒感染患者的预后极其重要。本文简要叙述COVID-19血栓形成机制,并对血栓危险因素及治疗进展作一系统综述。Novel coronavirus pneumonia (COVID-19) is a respiratory disease that spreads from person to person primarily through the respiratory tract and is caused by the SARS-CoV-2 virus. The spread of COVID-19 has resulted in a global pandemic and rapid expansion of the epidemic, posing an incalculable risk to human health and global economic development. Current research suggests that COVID-19 has undergone multiple mutations, is highly infectious, has an elevated viral load, and that the COVID-19 pandemic has greatly increased the risk of venous and arterial thromboembolic events in many patients;therefore, a comprehensive understanding of the risk of COVID-19 thrombosis and therapeutic advances are extremely important for the prognosis of patients with novel coronavirus infections. This article briefly describes the mechanism of COVID-19 thrombosis and provides a systematic review of thrombotic risk factors and therapeutic advances.展开更多
文摘目的探讨腹腔镜广泛性子宫全切术患者应用血栓风险评估对其术后下肢深静脉血栓(deep venous thrombosis,DVT)的预防效果。方法纳入2019年10月—2021年10月于新泰市人民医院行腹腔镜广泛性子宫全切术的98例患者,采用随机数字表法分为对照组和观察组,各49例。对照组行常规护理,观察组在常规护理基础上增加血栓风险评估指引下的护理。比较2组DVT发生率、术后恢复情况、凝血功能[凝血酶时间(thrombin time,TT)、凝血酶原时间(prothrombin time,PT)和活化部分凝血活酶时间(activated partial thromboplastin time,APTT)]、生活质量和护理满意度。结果干预后,观察组DVT发生率低于对照组,首次肛门排气时间、肠鸣音恢复时间、首次进食时间、下床活动时间和住院时间短于对照组,TT、PT、APTT水平高于对照组,健康调查简表(the MOS item short from health survey,SF-36)评分、护理满意度高于对照组,差异有统计学意义(P<0.05)。结论腹腔镜广泛性子宫全切术患者应用血栓风险评估可降低DVT发生率,改善患者的凝血功能,促进患者术后恢复,提高患者的生活质量和护理满意度,值得临床借鉴。
文摘新型冠状病毒肺炎(COVID-19)是一种呼吸道疾病,其主要通过呼吸道在人与人间传播,由SARS-CoV-2病毒引起。COVID-19经过传播导致疫病在全世界范围内大流行,快速扩张,对人类的健康及全球的经济发展造成了不可估量的危害。目前研究证据表明,COVID-19已发生多次变异,传染性极高,病毒载量增加,COVID-19大流行大大增加了许多患者发生静脉和动脉血栓栓塞事件的风险,因此,全面认识COVID-19血栓风险及治疗进展对新型冠状病毒感染患者的预后极其重要。本文简要叙述COVID-19血栓形成机制,并对血栓危险因素及治疗进展作一系统综述。Novel coronavirus pneumonia (COVID-19) is a respiratory disease that spreads from person to person primarily through the respiratory tract and is caused by the SARS-CoV-2 virus. The spread of COVID-19 has resulted in a global pandemic and rapid expansion of the epidemic, posing an incalculable risk to human health and global economic development. Current research suggests that COVID-19 has undergone multiple mutations, is highly infectious, has an elevated viral load, and that the COVID-19 pandemic has greatly increased the risk of venous and arterial thromboembolic events in many patients;therefore, a comprehensive understanding of the risk of COVID-19 thrombosis and therapeutic advances are extremely important for the prognosis of patients with novel coronavirus infections. This article briefly describes the mechanism of COVID-19 thrombosis and provides a systematic review of thrombotic risk factors and therapeutic advances.
